Neonatal Abstinence Syndrome (NAS) /Neonatal Opioid Withdrawal Syndrome (NOWS), Clinical Pathway, Inpatient
Neonatal Abstinence Syndrome (NAS) /Neonatal Opioid Withdrawal Syndrome (NOWS), Clinical Pathway, Inpatient
Goals and Metrics
Goals
- Optimize non-pharmacologic management for infants affected by Neonatal Abstinence Syndrome (NAS)/Neonatal Opioid Withdrawal Syndrome (NOWS)
- Maximize maternal-infant bonding and parental involvement in infant’s care
- Standardize treatment
Metrics
- Number of external visits to the pathway
- Decrease length of stay for infants affected by NAS/NOWS
- Decrease length of pharmacologic treatment, if required
- Track how often pathway recommendations were followed